Where Stem Cell Science, Meets Wall Street
NEW YORK, NY–(Marketwired – Oct 6, 2015) – Investor Conference Network will be holding what many are calling the largest and most significant gathering of private and publicly traded stem cell companies in New York City, on October 26th and 27th at the 1st Annual Stem Cell Investor Conference.
The invitation only conference has invited over 58 of the leading stem cell companies, including 39 from the U.S., seven from Australia, three from Israel and twelve others internationally, to present in front of hundreds of Wall Street institutional investors in the first “stem-cell-only” conference of its kind.
“A few years ago, the idea of using stem cells — undifferentiated human cells that are capable of morphing into specialized cells — to repair the human body seemed pretty far-fetched. But now, with several cellular products entering mid- and late-stage clinical testing, regenerative medicine is becoming a reality,” stated Roland Rick Perry conference Chairman and managing director of Institutional Analyst Inc., which publishes the Stem Cell Stock Review.
He added, “Stem cell processors such as Cynata Therapeutics from Melbourne, Australia have made amazing progress in recent years in developing novel methods for producing scalable quantities of mensenchymal stem cells for therapeutic applications that are independent of donor limitations. And International Stem Cell from Calsbad as another example, has created the first parthenogenetic homozygous stem cell line, with minimal immune rejection for hundreds of millions of individuals. These both can provide a tremendous aid to ongoing clinical trials being conducted throughout the world and makes for very exciting times in the field of stem cell science and an equally exciting conference.”
“The idea of regenerative medicine is a good one,” Mark Monane M.D., Chief Medical Officer at CardiDX, recently stated, pointing out that Americans spend around $300 billion annually on drugs that generally only treat the symptoms of disease or injury, while regenerative therapies could actually cure the condition. “People think regenerative medicine will be in the age of ‘The Jetsons,’ but it’s already here,” Monane added. “We’ve been doing bone-marrow transplants for about 50 years now.”
The 2015 Stem Cell Conference will be held at two separate NYC locations and is by invitation only with presentations from 9am to 5pm. Titled “Where Stem Cell Science, Meets Wall Street” the conference will feature presentations by CEOs and CFOs and expert panels moderated by industry leaders.
It is an opportunity for stem cell company management to meet the largest amount of Wall Street professionals possible interested in stem cell science, ever assembled under one roof. This event is geared to investment bankers, buy- and sell-side investment analysts, fund managers and venture capital firms.
For conference details and to see a list of invited presenters, visit http://www.stemcellinvestorconference.com
To ensure optimal all-day institutional attendance, presentation schedules will only be released the day of the conference, at the conference entrance. A limited number of attendance tickets for $1,195 will be available on a first come first serve basis. Admission is complimentary for institutional investors and press.
Contacts:
Company and Institutional Invitations:
Roland Rick Perry
Institutional Analyst Inc.
[email protected]
310-594-8062
Video Interviews:
Each presentation will be video taped and archived for later viewing at the the Stem Cell Investor Conference website and at the Biotech Exec TV website, by FMW Media Works – a leading financial broadcast provider. New To The Street will additionally be conducting “at conference” interviews with company executives to highlight late breaking news.
http://www.biotechexectv.com
http://www.newtothestreet.com
Video scheduling is handled by Vincent Caruso at 631-465-0284
Printed Interviews:
Wall Street Analyzer (WSA) will also be available to conduct in-depth executive interviews. WSA’s staff of writers, analysts goal is to produce informative interviews that will help investors understand a companies’ upside and provide direct access to company leadership.
http://wallstreetanalyzer.com/
Scheduling is handled by Juan Costello at 347-529-5734
Press Releases:
Each presenter receives a complimentary conference participation press release from NewsMediaWire the leading search optimized press release distribution service for news, photos and multimedia content from public and private corporations, non-profit organizations, colleges and universities, government agencies and other public sector organizations.
Contact Tom Speciale 561-852-2621
Sponsorships:
Sponsorship’s include web and event and a full page in the Stem Cell Investor Conference Guide. There are also sponsorship opportunities for the lunch and cocktail party. Ideal for public company service providers.
Please call Xavier Franco for details 310-924-4088
About Stem Cell Investor Conference:
The Stem Cell Investor Conference brings together both publicly traded and privately held stem cell companies and introduces their management directly to Wall Street. It is the only conference of its kind and designed to provide a forum where only Stem Cell related companies, network with select members of the institutional investment community.
While there are many medical technology and biotech conferences held throughout year, the Stem Cell Investor Conference presents just stem cell companies. The conference is additionally inviting a broader base of professional investors from all segments of the micro-cap market (between $50 and $300 million) to participate, including aggressive hedge funds experienced at investing at the micro-cap level.
About FMW MediaWorks/NTTS:
Produced by FMW Mediaworks, “New To The Street” paves the way to the latest financial issues, offering a blend of business and financial services news reporting and in-depth interviews relating to new products, economic analysis and public company profiles. FMW Media Works Corp. a leading provider of business profiles and corporate special programming, and airs as paid-programming on select stations nationwide including The History Channel and A&E. reaching more than 95 million homes. Visit http://www.newtothestreet.com.
About NewMediaWire:
By delivering news announcements and promotions in real time to thousands of national newspapers, broadcast outlets, search engines, news aggregators, individual journalists, blogs & websites, NewMediaWire helps drive traffic back to the issuers’ newsroom or website to share the corporate story. News releases reach journalists, consumers, bloggers & key influencers via NewMediaWire’s distribution channels, ultimately increasing the audience engagement.
Visit: http://app.newmediawire.com/
Contact Information:
Contact
Roland Rick Perry
Institutional Analyst Inc.
310-594-8062
[email protected]
Original: NewMediaWire
